HOMEVULNERABILITIESCVE-2026-34404
MEDIUM

CVE-2026-34404

CWE-400Published: March 31, 2026· Updated: Apr 1, 2026

6.9
CVSS v3.1
EPSS:0.04%probability of exploitation in 30 daysPercentile:12.9th

Official Description

Nuxt OG Image generates OG Images with Vue templates in Nuxt. Prior to version 6.2.5, the image‑generation component by the URI: /_og/d/ (and, in older versions, /og-image/) contains a Denial of Service (DoS) vulnerability. The issue arises because there is no restriction on the width and height parameters of the generated image. The vulnerability was reproduced using the standard configuration and the default templates. This issue has been patched in version 6.2.5.

NVD Source

Technical Analysis

CVE-2026-34404 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeX
Impact
Confidentiality
Integrity
Availability
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

All References (2)

Quick Facts

CVE IDCVE-2026-34404
CVSS Score6.9 / 10
SeverityMEDIUM
WeaknessCWE-400
CISA KEVNo
EPSS (30d)0.04%
PublishedMar 31, 2026

Related CVEs (CWE-400)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2026-34404 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.